ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 209,28
-0,12%
Dow Jones
39 431,51
-0,21%
DAX
18 742,22
-0,08%
Brent Oil
83,27
0,07%
Bitcoin
62 528,06
-0,60%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Genetic Technologies Ltd (GENE)

  7. Genetic Technologies Ltd (GENE) Actualités

GENE Genetic Technologies Ltd

2,44
0,15 (6,55%)
14 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Genetic Technologies Ltd GENE NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,15 6,55% 2,44 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,30 2,30 2,44 2,44 2,29
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/5/202414:00GLOBEGTG and ‘Wellworks for You’ sign B2B sales & marketing deal..
22/4/202421:00GLOBEGenetic Technologies Announces Closing of US$2 Million..
18/4/202418:17GLOBEGenetic Technologies Announces $2 Million Registered Direct..
17/4/202414:00GLOBENew Precision Oncology Tests to Drive Personalised Therapies..
16/4/202414:00GLOBEGeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year..
11/4/202414:00GLOBEGTG to pilot GeneType in Breast Screen centers across the..
08/4/202414:00GLOBEEVENT - Empowering Women Through Knowledge; Humanise Health..
02/4/202414:05GLOBEGenetic Technologies’ Digital Strategy Ignites Significant..
26/3/202413:00GLOBEGTG Global Collaborations and Innovation Update
25/3/202413:00GLOBEGENE to develop Worlds Most Advanced Comprehensive Risk Test..
26/2/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202420:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202414:00GLOBELaunching our most comprehensive test and expanding into new..
09/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202414:00GLOBEGenetic Technologies Regains Compliance with Nasdaq Minimum..
05/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
28/12/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202323:00EDGAR2Form F-3 - Registration statement by foreign private issuers
14/12/202314:00GLOBEGeneType's Groundbreaking Saliva Test Transforms Early..
12/12/202314:00GLOBEGenetic Technologies Limited Announces Ordinary Share..
30/10/202313:00GLOBEGene Business Update: Private Hospital Partnership; Expanded..
18/10/202314:30GLOBEGeneType Predicting Risk of Pancreatic Cancer: Major..
27/9/202315:00GLOBEGTG Signs Precision Medicine Pilot with Australia’s Largest..
12/9/202314:00GLOBEBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and..
11/9/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202314:30GLOBEGENE Positioned at the Forefront of Multi-cancer Clinical..
11/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202316:00GLOBEGenetic Technologies Limited and 60 Degrees Pharmaceuticals..
30/8/202314:45GLOBEAnnual Results – Momentum Building on our Commercial Plans
09/8/202314:00GLOBEGenetic Technologies Limited Announces Updated Investor..
28/7/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/7/202314:00GLOBEQuarterly Activities Update: Encouraging Growth for geneType..
21/7/202314:00GLOBEGenetic Technologies Receives Nasdaq Notification Regarding..
23/5/202314:00GLOBEGeneType featured on U.S. National TV to raise Breast Cancer..

Dernières Valeurs Consultées

NASDAQ
GENE
Genetic Technologies
ASX
LLCKOS
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés